These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8647992

  • 1. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
    van den Anker-Lugtenburg PJ, Heule F, Vanhagen PM, van Joost T, Oei HY, Löwenberg B, Krenning EP.
    J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
    Reubi JC, Waser B, van Hagen M, Lamberts SW, Krenning EP, Gebbers JO, Laissue JA.
    Int J Cancer; 1992 Apr 01; 50(6):895-900. PubMed ID: 1348240
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
    van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, Lamberts SW, Löwenberg B.
    Br J Haematol; 1996 Apr 01; 93(1):96-103. PubMed ID: 8611482
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin analogue scintigraphy in granulomatous diseases.
    Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogstede HC, Lamberts SW.
    Eur J Nucl Med; 1994 Jun 01; 21(6):497-502. PubMed ID: 8082663
    [Abstract] [Full Text] [Related]

  • 7. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan 01; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
    Albérini JL, Meunier B, Denzler B, Devillers A, Tass P, Dazord L, Le Simple T, Laissue J, de Jong R, Le Cloirec J, Reubi JC, Bourguet P.
    Breast Cancer Res Treat; 2000 May 01; 61(1):21-32. PubMed ID: 10930087
    [Abstract] [Full Text] [Related]

  • 9. The value of octreotide scintigraphy in patients with lung cancer.
    Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi JC, Laissue JA, Krenning EP.
    Eur J Nucl Med; 1994 Oct 01; 21(10):1106-13. PubMed ID: 7828621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
    Bares R, Galonska P, Dempke W, Handt S, Büll U, Osieka R.
    Horm Metab Res Suppl; 1993 Oct 01; 27():56-8. PubMed ID: 8330873
    [Abstract] [Full Text] [Related]

  • 12. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
    Baudin E, Lumbroso J, Schlumberger M, Leclere J, Giammarile F, Gardet P, Roche A, Travagli JP, Parmentier C.
    J Nucl Med; 1996 Jun 01; 37(6):912-6. PubMed ID: 8683310
    [Abstract] [Full Text] [Related]

  • 13. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R, Xiu Y, Zhuang HM, Alavi A.
    Br J Dermatol; 2006 Aug 01; 155(2):357-63. PubMed ID: 16882175
    [Abstract] [Full Text] [Related]

  • 14. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
    Banzo J, Abós MD, Prats E, García F, Freile E, Razola P, Escalera T.
    Rev Esp Med Nucl; 2001 Oct 01; 20(6):431-8. PubMed ID: 11578577
    [Abstract] [Full Text] [Related]

  • 15. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, Gomollón F, García F.
    Rev Esp Med Nucl; 2001 Feb 01; 20(1):11-8. PubMed ID: 11181324
    [Abstract] [Full Text] [Related]

  • 16. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
    Frilling A, Malago M, Martin H, Broelsch CE.
    Surgery; 1998 Dec 01; 124(6):1000-4. PubMed ID: 9854575
    [Abstract] [Full Text] [Related]

  • 17. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
    Slooter GD, Breeman WA, Marquet RL, Krenning EP, van Eijck CH.
    Int J Cancer; 1999 May 31; 81(5):767-71. PubMed ID: 10328231
    [Abstract] [Full Text] [Related]

  • 18. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.
    Dommann SN, Dommann-Scherrer CC, Ziegler T, Meyer J, Trüeb RM, Kündig T, Panizzon R, Burg G.
    Am J Dermatopathol; 1997 Aug 31; 19(4):391-5. PubMed ID: 9261475
    [Abstract] [Full Text] [Related]

  • 19. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
    Nilsson S, Reubi JC, Kalkner KM, Laissue JA, Horisberger U, Olerud C, Westlin JE.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5805s-5810s. PubMed ID: 7493350
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin-receptor scintigraphy in primary breast cancer.
    van Eijck CH, Krenning EP, Bootsma A, Oei HY, van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SW.
    Lancet; 1994 Mar 12; 343(8898):640-3. PubMed ID: 7906813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.